The initial public offering (IPO) of Anthem Biosciences was fully subscribed by the second day of bidding on Tuesday.The IPO ...

The mainline issue will close for public subscription on Wednesday, July 16. The basis of allotment of shares is likely to be ...

Among investor categories, Non-Institutional Investors (NIIs) have shown the highest interest, bidding 1.55 times their ...

Anthem Biosciences IPO got fully subscribed at 1.15 times on the second day of share sale on July 15. The initial share sale ...

Indian drugmaker Anthem Biosciences’ $395 million public listing was fully subscribed on the second day of bidding, as ...

New Delhi: The initial public offering (IPO) of Anthem Biosciences Ltd got fully subscribed on the day two of bidding on ...

Anthem Biosciences IPO opened for subscription on July 15, 2025, with a price band of Rs 540–570. The Rs 3,395 crore issue is entirely offer-for-sale (OFS) and will close on July 16.

The price band has been set at Rs 540 to Rs 570 per share. Investors can apply for a lot of 26 shares and in multiples of ...

Anthem Biosciences' Rs 3,395 crore IPO is fully subscribed on day 2. Details on subscription across investor categories and ...

Anthem Biosciences raised ₹1,016.02 crore from 60 institutional investors ahead of its IPO launch on July 14. The offering, ...

Anthem Biosciences has launched its IPO on July 14, closing on July 16. The ₹3,395 crore offer is entirely for sale by ...

Indian drugmaker Anthem Biosciences' ANTH.NS $395 million public listing was fully subscribed on the second day of bidding, as investors bet on the company's growth prospects at a time when global big ...